| | Online
Abstract Submission is closed | |
|
| Abstracts must be submitted
on-line via EANO2010 website. | | Deadline
abstract submission: Extended Deadline Abstract Submission:
March 19, 2010. | | Abstracts
sent by mail, fax or e-mail will NOT be accepted. |
| With the submission of an abstract to EANO IX,
the presenting author: |
| • | confirms
that all authors are aware of and agree to the content of the abstract and support
the data presented; | | • | accepts
to be the contact person for all correspondence about the abstract and inform
co-authors about its status; | | • | warrants
that the data and conclusions presented in the abstract have not been published
prior to the date of the EANO IX conference. Abstracts containing previously published
material will be rejected; | | • | states
that for studies involving human or animal subjects, permission has been obtained
from the relevant regulatory authority, and properly informed consent give where
appropriate; | | • | accepts
responsibility for the accuracy of the submitted abstract; | | • | acknowledges
that once the abstract is submitted, changes, corrections or rewording are possible
until deadline of abstract submission (March 19, 2010). |
| | Careful
typing and proof-reading are essential as the abstract will appear, if accepted,
as submitted. | | |
| ACCEPTANCE AND SELECTION OF ABSTRACTS |
| All submitted abstracts will be reviewed by the
Scientific Programme Committee in April 2010, and authors will be notified by
email at the latest begin of May 2010. Abstract selection: Some accepted abstracts
will be selected for oral presentation, some will be presented as posters. Accepted
abstracts will be published in an issue of the Neuro-Oncology journal. |
| |
| • | The
abstract must be submitted in good English. | | • | The
text must not exceed 2500 characters excluding spaces, title and authors |
| • | A maximum
of two institutions per author is allowed. | | • | No
more than 10 authors can be listed. | | • | No
tables, no graphs or illustrations are allowed. | | • | No
literature must be cited. | | | |
| Please select only ONE topic that refers to the
main subject of your abstract |
| 01. Cell biology and signalling
02. Epidemiology
03. Quality of life
04. Immunology and immunotherapy
05. In vitro /
in vivo models
06. Predictive biomolecular markers
07. New drug delivery
methods
08. Neuroimaging of brain tumours
09. Glioblastoma multiforme and
Anaplastic gliomas
10. Low grade gliomas
11. Pediatric brain tumours
12.
Meningiomas
13. Spinal cord tumours
14. Brain and leptomeningeal metastases
15.
Neurotoxicity and neuroprotection
16. Paraneoplastic neurological syndromes
17.
Supportive and palliative care | | |
|
